Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Submitted by
admin
on September 4, 2014 - 8:01am
Source:
Yahoo/Zacks.com
News Tags:
Arena Pharmaceuticals
APD811
orphan drugs
PAH
pulmonary arterial hypertension
Headline:
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Do Not Allow Advertisers to Use My Personal information
